Optimi Health Corp. (FRA:8BN)

Germany flag Germany · Delayed Price · Currency is EUR
0.198
-0.006 (-2.94%)
At close: Dec 4, 2025
41.43%
Market Cap 20.20M
Revenue (ttm) 342.25K
Net Income (ttm) -2.55M
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.208
Previous Close 0.204
Day's Range 0.198 - 0.208
52-Week Range 0.078 - 0.234
Beta n/a
RSI 44.43
Earnings Date Jan 29, 2026

About Optimi Health

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly k... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2020
Country Canada
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8BN
Full Company Profile

Financial Performance

In 2024, Optimi Health's revenue was 389,850, an increase of 115.28% compared to the previous year's 181,087. Losses were -6.04 million, 16.2% more than in 2023.

Financial numbers in CAD Financial Statements

News

There is no news available yet.